More Information on 'Cellec Biotek AG'

CELLEC Biotek AG is a company that develops and commercializes bioreactors for 3D cell culture and tissue generation. Their core product is the U-CUP perfusion bioreactor, a user-friendly tool designed to establish and control 3D cell and tissue cultures. The U-CUP system allows for direct perfusion, uniform cell seeding, and efficient nutrition and waste removal, creating a physiologically relevant tissue environment. It is suitable for various applications, including organotypic models, 3D cell expansion and differentiation, and investigation of cell-scaffold interactions. The company provides starter kits, disposable bioreactor kits, and other accessories, as well as scientific support and guidance for setting up experiments. CELLEC Biotek AG's products are used in research institutions and laboratories, particularly in the fields of tissue engineering, regenerative medicine, and life sciences.

About Cellec Biotek AG
CELLEC BIOTEK is a biotechnology startup founded in Basel (Switzerland) in February 2011 as a spin-off of Prof. Ivan Martin’s lab, a world leader expert of Tissue Engineering and Regenerative Medicine. Cellec develops and produces devices (the “bioreactors”) for 3D cell culture and tissue generation. The products allow to grow 3D living tissues, as (i) advanced model systems for tissue development and drug testing, targeting the life sciences and pharmacuetical research, and as (ii) biological grafts for tissue and organ regeneration, targeting the clinical translation in regenerative medicine. Cellec goal is to become a world leader company in the sector of 3D tissue culture systems.